tirzepatide fda approved for weight loss Grants a New Indication Obesity Management Tirzepatide Wins FDA Approval for

Every Tuesday, this new newsletter delivers clear-eyed, authoritative intelligence on the deals, decisions, policies, and power shifts shaping one of the worlds most consequential regions, written for the people who need to act on it

PlexusDx serves all 50 states without insurance requirements or membership fees, and semaglutide is HSA/FSA eligible, broadening access to patients seeking reliable, affordable GLP-1 therapy

Saxenda is administered as an injection once daily, whereas Wegovy is given as an injection once weekly

That long half-life means semaglutide already maintains relatively stable blood levels with weekly dosing

Options has shakes available if eating full meals is difficult when initiating the medications